feed,title,long_url,short_url
Benzinga,"Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says",https://benzinga.com/analyst-ratings/analyst-color/23/04/31792303/relay-therapeutics-stock-price-premium-vs-peers-is-justified-by-its-platform-techno,https://da.gd/txGX3
